BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16121917)

  • 21. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
    Oeda M; Hirabayashi N; Takiyama W; Nagamine I; Ohara M; Oshita A; Satou Y; Saeki S; Kirihara Y; Mukaida H; Hisamatu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1453-8. PubMed ID: 14584277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of remnant gastric cancer responding to neoadjuvant TS-1 therapy].
    Deguchi Y; Nashimoto A; Yabusaki H; Tanaka O; Sasaki J
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1449-52. PubMed ID: 11681256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
    Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
    Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
    Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
    Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
    N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case responding to weekly paclitaxel therapy as second-line chemotherapy for gastric cancer previously treated with TS-1].
    Imamura H; Furukawa H; Kishi K; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Shimizu J; Takemoto H; Kishimoto T; Kato H; Yamamoto K; Fujishima M; Kawasaki T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1693-5. PubMed ID: 15553685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma].
    Fujita T; Fukuda K; Nishi H; Takao T; Ohmura Y; Mano M; Komatsubara S; Yano T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1977-81. PubMed ID: 14650971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of recurrent gastric cancer at anastomosis medicated by TS-1].
    Morohashi H; Shibazaki I; Mitsui T; Murata K; Aizawa S; Hashizume T; Endo M; Nishizawa R
    Gan To Kagaku Ryoho; 2004 May; 31(5):767-9. PubMed ID: 15170990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Japanese nationwide post-marketing survey of S-1 in patients with advanced gastric cancer].
    Ohtsu A
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():52-6. PubMed ID: 16897972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
    Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An investigation of TS-1 single-agent therapy administered as first-line therapy for unresectable advanced gastric cancer].
    Nukaya H; Hirashima N; Tanaka Y; Endo M; Matsunaga S; Hasegawa I; Kato A; Sakakibara K; Sakamoto T; Kondo H
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1421-6. PubMed ID: 16227741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.
    Ako E; Ohira M; Yamashita Y; Kubo N; Muguruma K; Yashiro M; Sawada T; Nakata B; Kato Y; Hirakawa K
    Hepatogastroenterology; 2008; 55(86-87):1939-42. PubMed ID: 19102427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A self-expandable metallic stent in combination with cholangioscopic microwave coagulation therapy and chemotherapy with oral TS-1 against obstructive jaundice due to recurrent gastric cancer: a case report of successful treatment.
    Nio Y; Itakura M; Koike M; Omori H; Hashimoto K; Yano S; Higami T
    Anticancer Res; 2003; 23(2C):1795-801. PubMed ID: 12820461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of S-1 in patients with disseminated gastric cancer.
    Kitamura Y; Hayashi K; Sasagawa T; Oguma H; Takasaki K
    Drugs Exp Clin Res; 2003; 29(3):125-30. PubMed ID: 14708458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complete response in an elderly patient with advanced gastric cancer treated with TS-1].
    Ijuin H; Tokitou D; Adachi E; Imamura K; Imamura S; Arima T; Atsuchi Y; Nakano K; Kotobuki S
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2165-8. PubMed ID: 15628764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study.
    Koizumi W; Akiya T; Sato A; Sakuyama T; Sasaki E; Tomidokoro T; Hamada T; Fujimori M; Kikuchi Y; Shimada K; Mine T; Yamaguchi K; Sasaki T; Kurihara M
    Cancer Chemother Pharmacol; 2010 May; 65(6):1093-9. PubMed ID: 19727730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.